Cytodyn

Cytodyn

Cytodyn

CytoDyn is a biotechnology company focused on the development of new therapiesto combat infections with immune deficiency viruses.
Raised
$37.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,300,000
Venture capital - 2016
$33,270,000
Post-IPO equity - 2016
Team Size
1–10
Employees
GeekWire

Charlie Sheen shows interest in CytoDyn, which just raised $33M to develop 'functional cure' for HIV

Health